dma,This is the latest (6June2007). It was an announcement, to...

dma,
This is the latest (6June2007). It was an announcement, to be read by all who are interested.

"Ventracor Chief Executive Officer Peter Crosby said: “As of today, there have been 120 patients implanted with the VentrAssist worldwide who have collectively enjoyed approximately 55 patient years of support, with the longest duration support two years and eight months. The VentrAssist is the only third generation LVAD and the only centrifugal LVAD in clinical trials in the United States, and has the largest clinical experience of all third generation centrifugal devices.”

Ventracor is sponsoring two major US trials to be conducted in approximately 350 patients at up to 40 clinical sites. Details of the trials were published in the March 2007 Investor Update and are available on the Company’s website.

Mr. Crosby added: “We hope to complete patient enrolment in these two trials in approximately two years. This would put us well on the path towards achieving US regulatory approval with a leadership position to take advantage of a potentially huge world market.”

So, There you have it. Where did the "140" figure come from?